Literature DB >> 1864205

One gram of aspirin per day does not reduce risk of hospitalization for gallstone disease.

J H Kurata1, J Marks, D Abbey.   

Abstract

Data from 4524 patients in a randomized, controlled trial of aspirin were analyzed to determine if aspirin reduced the risk for hospitalization for gallstone disease. Aspirin at a dose of 1000 mg/day did not reduce the risk of hospitalization for gallstones. Hospitalization rates for gallstone disease were consistent with national rates, and the data confirmed previous associations of gallstone disease with age, elevated serum triglycerides, obesity, and female gender.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1864205     DOI: 10.1007/bf01297455

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  18 in total

1.  Prevention of gallstone recurrence by non-steroidal anti-inflammatory drugs.

Authors:  K Hood; D Gleeson; D C Ruppin; R H Dowling
Journal:  Lancet       Date:  1988-11-26       Impact factor: 79.321

Review 2.  Risk factors for the development of cholelithiasis in man (second of two parts).

Authors:  L J Bennion; S M Grundy
Journal:  N Engl J Med       Date:  1978-11-30       Impact factor: 91.245

3.  Effects of ursodeoxycholic acid and aspirin on the formation of lithogenic bile and gallstones during loss of weight.

Authors:  P H Broomfield; R Chopra; R C Sheinbaum; G G Bonorris; A Silverman; L J Schoenfield; J W Marks
Journal:  N Engl J Med       Date:  1988-12-15       Impact factor: 91.245

4.  The epidemiology of gallbladder disease: observations in the Framingham Study.

Authors:  G D Friedman; W B Kannel; T R Dawber
Journal:  J Chronic Dis       Date:  1966-03

5.  Plasma insulin, serum lipids and lipoproteins in gall stone disease in non-insulin dependent diabetic subjects: a case control study.

Authors:  M Laakso; M Suhonen; R Julkunen; K Pyörälä
Journal:  Gut       Date:  1990-03       Impact factor: 23.059

6.  Diet, alcohol, and relative weight in gall stone disease: a case-control study.

Authors:  R K Scragg; A J McMichael; P A Baghurst
Journal:  Br Med J (Clin Res Ed)       Date:  1984-04-14

7.  Prevalence of hyperlipoproteinemia in men with gallstone disease.

Authors:  R Kadziolka; S Nilsson; T Scherstén
Journal:  Scand J Gastroenterol       Date:  1977       Impact factor: 2.423

8.  Recruitment experience in the Aspirin Myocardial Infarction Study.

Authors:  J A Schoenberger
Journal:  Control Clin Trials       Date:  1987-12

9.  The epidemiology of gallstone disease in Rome, Italy. Part II. Factors associated with the disease. The Rome Group for Epidemiology and Prevention of Cholelithiasis (GREPCO).

Authors: 
Journal:  Hepatology       Date:  1988 Jul-Aug       Impact factor: 17.425

10.  Biliary colic treatment and acute cholecystitis prevention by prostaglandin inhibitor.

Authors:  G Goldman; P J Kahn; R Alon; T Wiznitzer
Journal:  Dig Dis Sci       Date:  1989-06       Impact factor: 3.199

View more
  5 in total

Review 1.  The inflammatory inception of gallbladder cancer.

Authors:  Jaime A Espinoza; Carolina Bizama; Patricia García; Catterina Ferreccio; Milind Javle; Juan F Miquel; Jill Koshiol; Juan C Roa
Journal:  Biochim Biophys Acta       Date:  2016-03-12

2.  Cholelithiasic disease and associated factors in a Spanish population.

Authors:  F Devesa; J Ferrando; M Caldentey; A Borghol; M J Moreno; A Nolasco; J Moncho; J Berenguer
Journal:  Dig Dis Sci       Date:  2001-07       Impact factor: 3.199

Review 3.  Body mass index, abdominal fatness and the risk of gallbladder disease.

Authors:  Dagfinn Aune; Teresa Norat; Lars J Vatten
Journal:  Eur J Epidemiol       Date:  2015-09-15       Impact factor: 8.082

Review 4.  Roles of infection, inflammation, and the immune system in cholesterol gallstone formation.

Authors:  Kirk J Maurer; Martin C Carey; James G Fox
Journal:  Gastroenterology       Date:  2008-12-25       Impact factor: 22.682

5.  Effect of NSAIDs on gallbladder bile composition.

Authors:  R K Sterling; M L Shiffman; H J Sugerman; E W Moore
Journal:  Dig Dis Sci       Date:  1995-10       Impact factor: 3.199

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.